Celltrion
068270.KS
#771
Rank
S$38.44 B
Marketcap
S$175.71
Share price
1.48%
Change (1 day)
10.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): S$1.11 Billion

According to Celltrion 's latest financial reports the company's current earnings are S$2.94 Billion. , an increase over its 2024 earnings that were of S$0.60 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 S$1.11 B84.38%
2024 S$0.60 B-8.89%
2023 S$0.66 B6.61%
2022 S$0.61 B-21.93%
2021 S$0.79 B10.28%
2020 S$0.71 B65.38%
2019 S$0.43 B16.74%
2018 S$0.37 B-33.93%
2017 S$0.56 B106.65%
2016 S$0.27 B25.18%
2015 S$0.21 B-6.4%
2014 S$0.23 B47.49%
2013 S$0.15 B-33.58%
2012 S$0.23 B
2010 S$0.12 B72.52%
2009 S$71.77 M258.3%
2008 S$20.03 M